136 related articles for article (PubMed ID: 6321384)
1. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
Oakes JE; Rector JT; Lausch RN
Invest Ophthalmol Vis Sci; 1984 Feb; 25(2):188-94. PubMed ID: 6321384
[TBL] [Abstract][Full Text] [Related]
2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
3. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
4. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
5. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
Rager-Zisman B; Allison AC
J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
[TBL] [Abstract][Full Text] [Related]
7. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
[TBL] [Abstract][Full Text] [Related]
8. [Effects of T cell subsets on mouse herpetic keratitis].
Yamashiro H
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):462-8. PubMed ID: 2220489
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
Leung KN; Nash AA; Sia DY; Wildy P
Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
[TBL] [Abstract][Full Text] [Related]
10. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
11. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes.
Le Gros GS; Prestidge RL; Watson JD
Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612
[TBL] [Abstract][Full Text] [Related]
12. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
Kohl S; Thomas JW; Loo LS
J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
[TBL] [Abstract][Full Text] [Related]
13. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
Pollard RB; Schmitt DA; Sasaki H; Hayashi Y; Suzuki F
Anticancer Res; 1990; 10(2A):285-90. PubMed ID: 2346302
[TBL] [Abstract][Full Text] [Related]
14. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.
Stohlman SA; Frelinger JA; Weiner LP
J Immunol; 1980 Apr; 124(4):1733-9. PubMed ID: 6245128
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis.
Meyers-Elliott RH; Chitjian PA; Billups CB
Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1170-80. PubMed ID: 3036742
[TBL] [Abstract][Full Text] [Related]
16. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis.
Russell RG; Nasisse MP; Larsen HS; Rouse BT
Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):938-44. PubMed ID: 6611324
[TBL] [Abstract][Full Text] [Related]
17. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
18. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis.
Whittum-Hudson J; Farazdaghi M; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1524-32. PubMed ID: 3877027
[TBL] [Abstract][Full Text] [Related]
19. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
[TBL] [Abstract][Full Text] [Related]
20. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1.
Ikemoto K; Pollard RB; Fukumoto T; Morimatsu M; Suzuki F
J Immunol; 1995 Aug; 155(3):1326-33. PubMed ID: 7636198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
